To further evaluate the tolerability of this combination, we determined whether it also kills normal circulating human lymphocytes, particularly CD4+ T cells, whose preservation can mediate anti-tumor immune responses and improve treatment responses [35, 36]. Here, CD4 is linked to neoplasm.